Engineered probiotics Clostridium butyricum <scp>‐pMTL007‐GLP</scp> ‐1 improves blood pressure via producing <scp>GLP</scp> ‐1 and modulating gut microbiota in spontaneous hypertension rat models-Reference-Cited by-同舟云学术

Engineered probiotics Clostridium butyricum ‐pMTL007‐GLP ‐1 improves blood pressure via producing GLP ‐1 and modulating gut microbiota in spontaneous hypertension rat models

Published:2022-12-18 Issue:4 Volume:16 Page:799-812
ISSN:1751-7915
Container-title:Microbial Biotechnology
language:en
Short-container-title:Microbial Biotechnology

Author:

Wang Xin‐liang¹²^ORCID,Chen Wen‐jie²^ORCID,Jin Rui²,Xu Xuan²,Wei Jing²,Huang Hong¹,Tang Yan‐hua³,Zou Chang‐wei¹,Chen Ting‐tao²^ORCID

Affiliation:

1. Key Laboratory of Poyang Lake Environment and Resource Utilization, School of Resources Environmental and Chemical Engineering Ministry of Education, Nanchang University Nanchang China

2. National Engineering Research Center for Bioengineering Drugs and Technologies Institute of Translational Medicine, Nanchang University Nanchang China

3. Department of Cardiovascular Surgery The Second Affiliated Hospital of Nanchang University Nanchang China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-7915.14196

Reference50 articles.

1. The Gut Microbiome in Hypertension

2. Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension